DAY ONE BIOPHARMACEUTICALS, INC. (DAWN) Technical Analysis

🔺 Technical Setup

📊 Technical Summary

DAY ONE BIOPHARMACEUTICALS, INC. (DAWN) closed at 21.53 (+0.00%). The chart remains in a constructive trend regime, with price holding above both the 50-day and 200-day moving averages. 20-day momentum is positive at +0.61%, with price is trading in the upper part of its roughly 52-week range (5.80–21.53), while ATR14 volatility is relatively contained at roughly 0.12% of price. RSI(14) is 80.3, which reflects strong upside momentum, although the indicator is approaching stretched territory. MACD remains below its signal line, which shows that momentum confirmation is still limited. The MACD histogram remains negative, suggesting momentum is still on the softer side. Recent trading volume is running below its typical 20-day average, which suggests participation remains relatively muted. Initial downside support sits near 18.81. Holding that area would help preserve the current chart structure. Latest fundamentals snapshot: Revenue: 39.80M · Net income: -19.73M · EPS (basic): -0.19. The interactive view adds overlays, pattern context and broader chart structure for deeper review.

Explore more